Luis P. Torres

FDA investigator

Appears on 2 documents from 2025 to 2026, mostly at sites in California. Most often cites control of microbiological contamination (21 CFR 211.113(b)).

2
Documents on file
9.0
Observations per 483
2025
First seen
2026
Most recent

What they cite most

From 18 observations

Activity by year

2025: 1, 2026: 1

Where

California 1 · North Carolina 1

Is Luis P. Torres coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

2 documents, newest first
FirmOpen
483 K.C. Pharmaceuticals, Inc.Feb 13, 2026 · Pomona, California
483 Glenmark Pharmaceuticals Inc.Jun 17, 2025 · Monroe, North Carolina

About this profile

What does Luis P. Torres inspect?

Luis P. Torres appears on 2 documents on file covering 2 sites, mostly in California.

What do they cite most often?

21 CFR 211.113(b) (control of microbiological contamination), followed by 21 CFR 211.22(a) and 21 CFR 211.84(d)(2).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Luis P. Torres is dated Feb 13, 2026.